Engineering of a third-generation chimeric antigen receptor with specificity for HLA-A2 for use in regulatory T cell therapy
<p><strong>Background:</strong></p> <p>Current pharmacologic regimes of immunosuppression for allogeneic transplant recipients increase vulnerability to cancers and infections due to their systemic mode of action, in addition to side effects such as organ toxicity. Furt...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
2022
|
| Subjects: |